These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 37972067)
1. A peptidomimetic modulator of the Ca Gomez K; Santiago U; Nelson TS; Allen HN; Calderon-Rivera A; Hestehave S; Rodríguez Palma EJ; Zhou Y; Duran P; Loya-Lopez S; Zhu E; Kumar U; Shields R; Koseli E; McKiver B; Giuvelis D; Zuo W; Inyang KE; Dorame A; Chefdeville A; Ran D; Perez-Miller S; Lu Y; Liu X; Handoko ; Arora PS; Patek M; Moutal A; Khanna M; Hu H; Laumet G; King T; Wang J; Damaj MI; Korczeniewska OA; Camacho CJ; Khanna R Proc Natl Acad Sci U S A; 2023 Nov; 120(47):e2305215120. PubMed ID: 37972067 [TBL] [Abstract][Full Text] [Related]
2. Peptide and Peptidomimetic Inhibitors Targeting the Interaction of Collapsin Response Mediator Protein 2 with the N-Type Calcium Channel for Pain Relief. Perez-Miller S; Gomez K; Khanna R ACS Pharmacol Transl Sci; 2024 Jul; 7(7):1916-1936. PubMed ID: 39022365 [TBL] [Abstract][Full Text] [Related]
3. A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors. François-Moutal L; Wang Y; Moutal A; Cottier KE; Melemedjian OK; Yang X; Wang Y; Ju W; Largent-Milnes TM; Khanna M; Vanderah TW; Khanna R Pain; 2015 Jul; 156(7):1247-1264. PubMed ID: 25782368 [TBL] [Abstract][Full Text] [Related]
4. Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential. Xie JY; Chew LA; Yang X; Wang Y; Qu C; Wang Y; Federici LM; Fitz SD; Ripsch MS; Due MR; Moutal A; Khanna M; White FA; Vanderah TW; Johnson PL; Porreca F; Khanna R Pain; 2016 Sep; 157(9):2124-2140. PubMed ID: 27537210 [TBL] [Abstract][Full Text] [Related]
5. Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides. Moutal A; Li W; Wang Y; Ju W; Luo S; Cai S; François-Moutal L; Perez-Miller S; Hu J; Dustrude ET; Vanderah TW; Gokhale V; Khanna M; Khanna R Br J Pharmacol; 2018 Jun; 175(12):2244-2260. PubMed ID: 28161890 [TBL] [Abstract][Full Text] [Related]
6. Uncoupling the CRMP2-Ca Allen HN; Hestehave S; Duran P; Nelson TS; Khanna R J Pain; 2024 Dec; 25(12):104664. PubMed ID: 39233208 [TBL] [Abstract][Full Text] [Related]
7. Sustained relief of neuropathic pain by AAV-targeted expression of CBD3 peptide in rat dorsal root ganglion. Fischer G; Pan B; Vilceanu D; Hogan QH; Yu H Gene Ther; 2014 Jan; 21(1):44-51. PubMed ID: 24152582 [TBL] [Abstract][Full Text] [Related]
8. Activity of T-type calcium channels is independent of CRMP2 in sensory neurons. Cai S; Shan Z; Zhang Z; Moutal A; Khanna R Channels (Austin); 2019 Dec; 13(1):147-152. PubMed ID: 31025580 [TBL] [Abstract][Full Text] [Related]
10. CRMP2-Neurofibromin Interface Drives NF1-related Pain. Moutal A; Sun L; Yang X; Li W; Cai S; Luo S; Khanna R Neuroscience; 2018 Jun; 381():79-90. PubMed ID: 29655575 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of transmitter release and attenuation of anti-retroviral-associated and tibial nerve injury-related painful peripheral neuropathy by novel synthetic Ca2+ channel peptides. Wilson SM; Schmutzler BS; Brittain JM; Dustrude ET; Ripsch MS; Pellman JJ; Yeum TS; Hurley JH; Hingtgen CM; White FA; Khanna R J Biol Chem; 2012 Oct; 287(42):35065-35077. PubMed ID: 22891239 [TBL] [Abstract][Full Text] [Related]
12. Dissecting the role of the CRMP2-neurofibromin complex on pain behaviors. Moutal A; Wang Y; Yang X; Ji Y; Luo S; Dorame A; Bellampalli SS; Chew LA; Cai S; Dustrude ET; Keener JE; Marty MT; Vanderah TW; Khanna R Pain; 2017 Nov; 158(11):2203-2221. PubMed ID: 28767512 [TBL] [Abstract][Full Text] [Related]
13. (S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology. Moutal A; Chew LA; Yang X; Wang Y; Yeon SK; Telemi E; Meroueh S; Park KD; Shrinivasan R; Gilbraith KB; Qu C; Xie JY; Patwardhan A; Vanderah TW; Khanna M; Porreca F; Khanna R Pain; 2016 Jul; 157(7):1448-1463. PubMed ID: 26967696 [TBL] [Abstract][Full Text] [Related]
14. Uncoupling the CRMP2-Ca Allen HN; Hestehave S; Duran P; Nelson TS; Khanna R bioRxiv; 2024 Jun; ():. PubMed ID: 38895294 [TBL] [Abstract][Full Text] [Related]
15. Regulation of N-type voltage-gated calcium channels (Cav2.2) and transmitter release by collapsin response mediator protein-2 (CRMP-2) in sensory neurons. Chi XX; Schmutzler BS; Brittain JM; Wang Y; Hingtgen CM; Nicol GD; Khanna R J Cell Sci; 2009 Dec; 122(Pt 23):4351-62. PubMed ID: 19903690 [TBL] [Abstract][Full Text] [Related]